Valuation: Renata PLC

Market Cap 53.21B 432M 378M 349M 322M 611M 41.21B 621M 4.16B 1.64B 20.3B 1.62B 1.59B 69.79B P/E 2026 *
18.9x
P/E 2027 * 12.8x
Enterprise Value 53.21B 432M 378M 349M 322M 611M 41.21B 621M 4.16B 1.64B 20.3B 1.62B 1.59B 69.79B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.97x
Free-Float
17.05%
Yield 2026 *
1.23%
Yield 2027 * 3.15%
1 day+0.74%
1 week+0.11%
Current month+1.73%
1 month+8.97%
3 months+10.09%
6 months+21.06%
Current year+18.40%
1 week 457.2
Extreme 457.2
464.9
1 month 426
Extreme 426
466.9
Current year 381.8
Extreme 381.8
488
1 year 372
Extreme 372
548
3 years 372
Extreme 372
1,217.9
5 years 372
Extreme 372
1,289.72
10 years 372
Extreme 372
1,289.72
Manager TitleAgeSince
Chief Executive Officer - 2001-12-31
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 2001-12-31
Chairman 84 -
Director/Board Member - 2013-08-26
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+0.11%-5.07%-61.91% 432M
-2.33%-2.09%+49.88%+169.76% 1,060B
-0.82%-2.30%+63.79%+62.56% 619B
-0.73%-4.98%+28.91%+83.79% 438B
-0.03%+1.48%+30.66%+25.82% 333B
+0.13%-0.38%+29.23%+47.30% 282B
-0.71%-9.21%+20.07%+23.93% 267B
+0.20%+0.64%-27.10%-38.20% 218B
-0.06%-2.88%+23.07%+61.02% 196B
-3.72%-1.10%+18.41%+69.98% 161B
Average -0.74%-3.00%+23.19%+44.41% 357.43B
Weighted average by Cap. -1.13%-3.10%+36.48%+83.53%

Financials

2026 *2027 *
Net sales 47.45B 385M 337M 311M 287M 545M 36.75B 554M 3.71B 1.46B 18.1B 1.45B 1.42B 62.23B 55.08B 447M 391M 361M 333M 632M 42.66B 643M 4.31B 1.69B 21.02B 1.68B 1.64B 72.25B
Net income 2.81B 22.83M 19.97M 18.42M 17.01M 32.28M 2.18B 32.82M 220M 86.42M 1.07B 85.72M 83.85M 3.69B 4.39B 35.63M 31.16M 28.74M 26.55M 50.37M 3.4B 51.22M 343M 135M 1.67B 134M 131M 5.75B
Net Debt - -
Logo Renata PLC
Renata PLC is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing, marketing and distribution of pharmaceuticals, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. It operates in several modalities, such as oral solids dosage forms, which include tablets, capsules, OROS, oral dispersible tablets; soft gels injectables, which include hormone injectables, general injectables and oncology injectables; inhalers, which include DPI and MDI, and nutraceutical products. Its offering includes anthelmintic, live vaccines, nutrition products, vitamins & minerals, anti-gout, anti-spasmodic, and anti-allergic. The Company has approximately 14 manufacturing facilities spread over three manufacturing sites.
Employees
8,366
Date Price Change Volume
26-07-12 BDT 463.90 +0.74% 30,405
26-07-09 BDT 460.50 +0.20% 25,470
26-07-08 BDT 459.60 -0.28% 26,216
26-07-07 BDT 460.90 -0.58% 29,732
26-07-06 BDT 463.60 +0.04% 40,343
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
463.90BDT
Average target price
615.05BDT
Spread / Average Target
+32.58%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENATA Stock